Amir London, CEO of Israeli biotech Kamada, was interviewed on ILTV Daily about Kamada’s protein purification treatments for lung disease and rabies.  Kamada’s Glassia is also being tested for treating Type 1 diabetes, GVHD and the rejection of bone marrow … Continue reading →

Israel’s 2019 Genesis Prize winner, Natan Sharansky, donated his $1 million prize to 10 Israeli startups developing innovations to combat Covid-19. The 10 are Kamada, Pluristem, Sight Diagnostics, Sonovia, Biobeat, EyeControl, K Health, Picodya, IAI and MyZeppi. https://nocamels.com/2020/12/sharansky-genesis-prize-10-companies-covid/ https://www.genesisprize.org/press-center/2020-12-24-genesis-prize-and-start-up-nation-central-announce-winners-of-the-competition-in-honor-of-natan-sharansky

Israel’s Kamada (reported here previously) has signed a deal to supply Israel’s Health ministry with its plasma-based hyperimmune immunoglobulin (IgG) product. The product treats COVID-19 patients with pneumonia and is currently in Phase 1 & 2 trials in Israel. https://nocamels.com/2020/10/kamada-deal-supply-israel-health-ministry-covid-19-antibody/ … Continue reading →

11 of the 12 trial patients treated with the IgG Covid-19 treatment from Israel’s Kamada (reported here previously) have now recovered and been discharged from hospital. https://nocamels.com/2020/09/early-trial-results-kamada-covid-19-antibodies/

Three of the first critical Covid-19 patients treated with the new IgG plasma-derived “passive vaccine” product developed by Israel’s Kamada and Hadassah Medical Center (reported here previously), have made a rapid recovery and have now been discharged from Hadassah hospital. … Continue reading →

Jerusalem’s Hadassah Hospital is cautiously optimistic after the world’s first passive immunization of a critically ill coronavirus patient. After an injection of Kamada’s IgG antibody product (see here), a CT-scan of the lungs showed some improvement and doctors are hopeful … Continue reading →

Israel’s Kamada (reported here previously) has completed manufacturing the first batch of its plasma-derived Immunoglobulin G (IgG) product for Covid-19 patients. Initial vials of the antibody have been made available for compassionate use in Israel. https://www.calcalistech.com/ctech/articles/0,7340,L-3834010,00.html

Israeli biotech Kamada (see here) has partnered Italy’s Kedrion to develop a human plasma-derived Anti-SARs-COV-2 product. Kamada will use its proprietary IgG platform technology and Kedrion will provide plasma from donors who have recovered from the virus. https://www.kedrion.com/kedrion-and-kamada-announce-collaboration-anti-covid-19-igg-0

This article focuses on six Israeli startups. RADLogics (diagnoses lung infection), Sight Diagnostics (blood test), Kamada (antibodies), Clew Medical (severity monitoring), EarlySense (home monitoring) and Geneyx Genomex (genetic resistance analysis). https://www.calcalistech.com/ctech/articles/0,7340,L-3803020,00.html http://radlogics.com/  https://www.youtube.com/watch?v=Ro50KjWWbXg https://geneyx.com/  https://www.youtube.com/watch?v=FvjpxVNsLK4